SCHEMBL8992799

SCHEMBL8992799

COc1cccc(Cc2ccc(CO[Si](C)(C)C(C)(C)C)cc2C)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.46
AGXT P21549 2/20 0.46
DHFR P00374 1/20 0.44
CNR2 P34972 3/20 0.42
GPR55 Q9Y2T6 2/20 0.42
CNR1 P21554 2/20 0.42
MAOB P27338 4/20 0.41
FGFR1 P11362 1/20 0.40
FGFR4 P22455 1/20 0.40
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ABCB1 P08183 1/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR1B P28222 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15778630 0.86 IDO1 (0.60) IDO1AGXTMAOBABCB1HTR1A
SCHEMBL8993203 0.83 CNR2 (0.44) IDO1AGXTDHFRCNR2GPR55
SCHEMBL30079928 0.80 USP14 (0.35) IDO1
SCHEMBL8993225 0.77 IDH1 (0.47) IDO1AGXTDHFRCNR2GPR55
SCHEMBL8993136 0.77 CNR2 (0.46) IDO1AGXTDHFRCNR2GPR55
SCHEMBL29718974 0.77 MTNR1A (0.42) IDO1AGXTDHFRCNR2GPR55
SCHEMBL26906256 0.77 MTNR1A (0.42) IDO1AGXTDHFRCNR2GPR55
SCHEMBL30079875 0.75 USP14 (0.35)
SCHEMBL22275629 0.75 USP14 (0.35)
SCHEMBL8992732 0.75 BRD4 (0.40) IDO1AGXTMAOBCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed